SEARCH RESULTS FOR: "Tag: ARWR"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(4)
2018(7)
2016(6)
2015(12)
2014(2)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(4)
Buzz Stocks(6)
Earnings Preview(1)
Ezines(1)
General(7)
Intraday Option Activity(3)
Market Recap(1)
Midday Market Check(3)
Opening View(1)
Options Recommendations(1)
Quantitative Analysis(2)
Stock Market News(3)
Stocks On the Move(6)
The Week Ahead(1)
Unusual Trading Activity(1)

10/24/2019 9:59 AM
Gene silencing expert Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) has been a major winner in 2019. The shares are up more than 200% year-to-date and have added 41% in the past month alone, while yest...
8/2/2019 12:26 PM
A big biotech winner lately has been Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), which recently outperformed the broad market sell-off yesterday. ARWR nabbed an 11-year high of $30.73 on July 22, but...
5/21/2019 3:24 PM
U.S. markets are moving higher today, tech recovering from yesterday's sell-off. Three pharmaceutical names also making notable moves this afternoon are Array Biopharma Inc (NASDAQ:ARRY), Sesen Bio...
5/21/2019 12:04 PM
U.S. stocks are pushing higher today thanks to the more lenient stance taken against Huawei by the Trump administration. The Dow is trading well into triple-digit territory, and gains from the tech...
10/4/2018 10:47 AM
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced a $3.7 billion licensing deal with Janssen Pharmaceuticals -- a division of Johnson & Johnson (NYSE:JNJ) -- to develop and market its gene-silenci...
Partner Center